E-DRUG Archives (by thread)

  • [e-drug] INCB: Abuse of prescription drugs surpasses narcotic drug abuse, E-Drug
  • [e-drug] Commodities Logistics Manager position in Abuja, Nigeria, Joyce Prescott
  • [e-drug] ARV Drug Supply Management Training, 3-16 June in South Africa, BeckmannM
  • [e-drug] XDR tuberculosis spreads across South Africa, E-drug
  • [e-drug] MSF study on 2nd line ART: Access problem severe, Buddhima Lokuge
  • [e-drug] Launch of new non-patented Low-Cost Antimalaria medicine, Buddhima Lokuge
  • [e-drug] Invitation for Expressions of Interest for EC project, Bonsmann, Christoph
  • [e-drug] INCB: Abuse of prescription drugs surpasses narcotic drug abuse (3), Jonathan Harper
  • [e-drug] Polio eradication in Indian Journal Medical Research Jan 2007, Dr Gopal Dabade
  • [e-drug] Novartis request for MEPs not to sign, Alexandra HEUMBER
  • [e-drug] Seminar on Equitable Access to Medicines for Malaysians, Zaheer-Ud-Din Babar
  • [e-drug] Boehringer blocks access to AIDS syrup for children, BUKO Pharma-Kampagne
  • [e-drug] Vasella questioned about Novartis legal action against India, Alexandra HEUMBER
  • [e-drug] heat stable oxytocin?, Leontien Laterveer
  • [e-drug] Polio Eradication in India, Dr.S.Gopal krishnan
  • [e-drug] Analysis of the World Bank's pharmaceutical lending, E-Drug
  • [e-drug] Combivir patent rejected in China, James ARKINSTALL
  • [e-drug] Drug prices in India, Dr Gopal Dabade
  • [e-drug] Profits and drug companies in India, Dr Gopal Dabade
  • [e-drug] Summer Courses in 'Policy Analysis' and ' Drug Safety', Pieter Stolk
  • [e-drug] Therapeutics Letter #62: Mild Hypertension, Ciprian Jauca
  • [e-drug] Safety of anaemia drug erythropoietin is to be reviewed, Pal, Shanthi N.
  • [e-drug] Vacancy Announcement Procurement Officer with UNOPS, vacanciesbkk
  • [e-drug] Generic drugs - Times of India Editorial March 9, Alexandra HEUMBER
  • [e-drug] UNOPS Vacancy - Senior Pharmaceutical Product / Supply Chain Officer, Nirmal WALIA
  • [e-drug] UNOPS Vacancy Announcement - M&E Officer, Nirmal WALIA
  • [e-drug] Vacancy - Director, UNOPS India Office, Nirmal WALIA
  • [e-drug] RFI: Standard Treatment Guidelines methodology?, Naarendorp Miriam
  • [e-drug] Kenya Medicine Prices Monitor, HAI Africa
  • [e-drug] WHO-led anti-counterfeiting coalition, Leela McCullough
  • [e-drug] Open Courseware on pharmaceuticals, Hilbrand Haak
  • [e-drug] Heat stable oxytocin? (7), psmint@iinet.net.au
  • [e-drug] Bangkok?s Drug War Goes Global (2), Buddhima Lokuge
  • [e-drug] Abbott Registration Practices, B . Baker
  • [e-drug] European Commission on Indian drugs case, Alexandra HEUMBER
  • [e-drug] WHO-led anti-counterfeiting coalition (2), Jorg Schaaber
  • [e-drug] Abbott Escalates Thai Patent Rift, E-Drug
  • [e-drug] Books on Pills, Nwokike,Jude
  • [e-drug] Friday U.S. Capitol Hill Briefing on Thailand Situation, Judit Rius Sanjuan
  • [e-drug] World Consumer Day 15th March - Unethical Drug Promotion, Mira Shiva
  • [e-drug] Books on Pills (4), Alan Cassels
  • [e-drug] Heat stable oxytocin? (10), Tom Layloff
  • [e-drug] Abbott Withdraws Seven Medicines in Thailand, B . Baker
  • [e-drug] MSF Denounces Abbott, Buddhima Lokuge
  • [e-drug] Books on Pills (5), JBRusso
  • [e-drug] Books on Pills (6), Montagne, Michael
  • [e-drug] Pharmacists needed for South Sudan, cleo . chadwick
  • [e-drug] MSF Access Campaign is recruiting a Pharmacist full time in India, Fernando Pascual
  • [e-drug] World Consumer Day 15th March - Unethical Drug Promotion (2), Dr. Subhash C Mandal
  • [e-drug] C&F or FOB, sarita boolell
  • [e-drug] Books on Pills (9), Lisa Forman
  • [e-drug] C&F or FOB (2), K.F.Steinhausen
  • [e-drug] Activists push for global boycott, Kannikar KIJTIWATCHAKUL
  • [e-drug] Abbott CEO's remuneration, Kannikar KIJTIWATCHAKUL
  • [e-drug] C&F or FOB (3), Wilbert Bannenberg
  • [e-drug] C&F or FOB (4), nilakantha bhoi
  • [e-drug] RFI Macular degeneration Tx?, "Rannveig Einarsdóttir"
  • [e-drug] Creating off-label uses? (2), Larry Sasich
  • [e-drug] Studies about Yemen?, nabil gedadi
  • [e-drug] TRIPS-plus IP rules in the US-Jordan FTA, Elizabeth Wabuge
  • [e-drug] Editorial: Putting meaning back into TRIPS, Sarah Rimmington
  • [e-drug] Scarcity of essential (?) medicines (3), Valeria Frighi
  • [e-drug] Lancet: WHO must defend patients' interests, not industry, nathan ford
  • [e-drug] Lancet (book review): Access to essential medicines & the pendulum of power, nathan ford
  • [e-drug] List of Books on Pills, Beverley Snell
  • [e-drug] Doxycycline induced oesophagitis, Mark Nichter
  • [e-drug] BMJ: WHO Confronts Chinese Company Over Malaria Drug, Waning, Brenda
  • [e-drug] Doxycycline induced oesophagitis (3), AbdurRafiu A. Idris
  • [e-drug] Doxycycline induced oesophagitis (2), Pipasha Biswas
  • [e-drug] WHO to reduce stavudine dose from 40 to 30mg?, sharonann . lynch
  • [e-drug] AZT v stavudine, Beverley Snell
  • [e-drug] Creating off-label uses (3) - sales reps, Christophe Kopp
  • [e-drug] Medicine Prices in Malaysia - PLoS Medicine Paper, Zaheer-Ud-Din Babar
  • [e-drug] Deadly TB strain thrives in African slums, e-drug
  • [e-drug] HPV vaccine, Lambert Marie
  • [e-drug] IDA Solutions - vacancies, Clarisse Morris
  • [e-drug] Remifentanil vs fentanyl, Atieno Ojoo
  • [e-drug] Beyond WHO Stop TB?, Wilbert Bannenberg
  • [e-drug] Vaccination campaign funded by drug firm, e-drug
    • Mail converted by MHonArc 2.6.8